Form 4: Select Medical Holdings Corp: Co-President Mullin Receives 100,000 Shares of Restricted Stock

Sentiment:

SEC Form 4 Filing


Thomas P. Mullin, Co-President of Select Medical Holdings Corp, acquired 100,000 shares of restricted stock on April 30, 2024, which will vest on April 30, 2027.

Summary

  • On April 30, 2024, Thomas P. Mullin, Co-President of Select Medical Holdings Corp, acquired 100,000 shares of common stock.
  • These shares were granted as restricted stock.
  • The restricted stock will vest in full on April 30, 2027, which is the third anniversary of the grant date.
  • Following the transaction, Mullin directly owns 394,269 shares of Select Medical Holdings Corp.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports a standard transaction of restricted stock grant to an executive. It's neither particularly positive nor negative.

Positives

  • The acquisition of restricted stock by a company executive can be seen as a positive sign, aligning the executive's interests with those of the shareholders.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency regarding the holdings of company insiders.

Stakeholder Impact

  • The transaction could have a minor positive impact on shareholder sentiment due to the alignment of executive and shareholder interests.

Key Dates

DateDescription
04/30/2024Date of transaction: Mullin acquired 100,000 shares of restricted stock.
04/30/2027Vesting date: Restricted stock will vest in full on this date.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.